We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
AVLN icon
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB icon
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
STX icon
101
Seagate
STX
$167B
$22.8M 0.31%
23,637
+1,990
+9% +$1.52M
2025 Q3
3 quarters
MSI icon
102
Motorola Solutions
MSI
$74.3B
$22.4M 0.3%
54,014
+1,433
+3% +$600K
2024 Q3
7 quarters
DNTH icon
103
Dianthus Therapeutics
DNTH
$4.36B
$22M 0.29%
225,261
– –
2026 Q1
1 quarter
MLM icon
104
Martin Marietta Materials
MLM
$33.8B
$21.6M 0.29%
37,385
+34,477
+1,186% +$20.4M
2025 Q4
2 quarters
WEC icon
105
WEC Energy
WEC
$34.5B
$21.1M 0.28%
179,606
-29,466
-14% -$3.36M
2024 Q4
6 quarters
GKOS icon
106
Glaukos
GKOS
$9.99B
$21M 0.28%
150,036
– –
2025 Q1
5 quarters
CRDO icon
107
Credo Technology Group
CRDO
$36.7B
$20.9M 0.28%
77,348
+74,650
+2,767% +$14.7M
2025 Q2
4 quarters
SION icon
108
Sionna Therapeutics
SION
$200M
$20.9M 0.28%
474,981
-170,549
-26% -$6.82M
2025 Q4
2 quarters
MU icon
109
Micron Technology
MU
$1.06T
$20.9M 0.28%
18,164
+312
+2% +$234K
2024 Q4
6 quarters
AVGO icon
110
Broadcom
AVGO
$1.7T
$20.8M 0.28%
55,303
-3,814
-6% -$1.53M
2024 Q4
6 quarters
CELC icon
111
Celcuity
CELC
$3.12B
$20.6M 0.28%
196,770
-47,129
-19% -$5.44M
2024 Q1
9 quarters
AJG icon
112
Arthur J. Gallagher & Co
AJG
$59.9B
$19.9M 0.27%
86,769
+3,099
+4% +$658K
2022 Q3
15 quarters
STRO icon
113
Sutro Biopharma
STRO
$182M
$19.4M 0.26%
585,262
-130,045
-18% -$4.05M
2026 Q1
1 quarter
CEG icon
114
Constellation Energy
CEG
$105B
$19.3M 0.26%
77,125
-983
-1% -$277K
2024 Q1
9 quarters
PRVA icon
115
Privia Health
PRVA
$2.78B
$19M 0.25%
737,694
– –
2022 Q2
16 quarters
HTFL icon
116
Heartflow Inc
HTFL
$4.41B
$18.7M 0.25%
636,942
-120,014
-16% -$3.6M
2025 Q3
3 quarters
WGS icon
117
GeneDx Holdings
WGS
$1.96B
$18.5M 0.25%
269,542
-189,473
-41% -$10.8M
2026 Q1
1 quarter
SYRE icon
118
Spyre Therapeutics
SYRE
$7.76B
$17.9M 0.24%
+201,616
New +$14.7M
2026 Q2
0 quarters
EYPT icon
119
EyePoint Inc
EYPT
$270M
$17.8M 0.24%
1,245,583
– –
2026 Q1
1 quarter
TSM icon
120
TSMC
TSM
$2.3T
$17.5M 0.23%
37,413
-2,964
-7% -$1.2M
2025 Q2
4 quarters
RBRK icon
121
Rubrik
RBRK
$24.7B
$17.4M 0.23%
216,431
+204,826
+1,765% +$12.9M
2024 Q4
6 quarters
BKH icon
122
Black Hills Corp
BKH
$5.89B
$17.2M 0.23%
+230,351
New +$17M
2026 Q2
0 quarters
AKTS icon
123
Aktis Oncology
AKTS
$935M
$16.3M 0.22%
507,000
– –
2026 Q1
1 quarter
GRMN icon
124
Garmin
GRMN
$53.1B
$16.2M 0.22%
68,279
-2,626
-4% -$639K
2025 Q1
5 quarters
EVMN icon
125
Evommune Inc
EVMN
$216M
$16.1M 0.21%
1,209,129
– –
2025 Q4
2 quarters
3 4
5
6 7

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.